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The paramyxovirus fusion (F) protein mediates membrane fusion. The biologically active F protein consists of a membrane
distal subunit, F2, and a membrane-anchored subunit, F1. We have identified a highly stable structure composed of peptides
derived from the F1 heptad repeat A, which abuts the hydrophobic fusion peptide (peptide N-1), and the F1 heptad repeat B,
located 270 residues downstream and adjacent to the transmembrane domain (peptides C-1 and C-2). In isolation, peptide
N-1 is 47% a-helical and peptide C-1 and C-2 are unfolded. When mixed together, peptides N1 1 C1 form a thermostable (Tm
.90°C), 82% a-helical, discrete trimer of heterodimers (mass 31,300 Mr) that is resistant to denaturation by 2% SDS at 40°C.
We suggest that this a-helical trimeric complex represents the core most stable form of the F protein that either is fusion
competent or forms after fusion has occurred. Peptide C-1 is a potent inhibitor of both the lipid mixing and the aqueous
content mixing fusion activity of the SV5 F protein. In contrast, peptides N-1 and N-2 inhibit cytoplasmic content mixing but
not lipid mixing, leading to a stable hemifusion state. Thus, these peptides define functionally different steps in the fusion
process. The parallels among both the fusion processes and the protein structures of paramyxovirus F proteins, HIV gp41,
and influenza virus hemagglutinin are discussed, as the analogies are indicative of a conserved paradigm for fusion
promotion among fusion proteins from widely disparate viruses. © 1998 Academic Press
INTRODUCTION
Fusion of the membrane of enveloped viruses with
cellular membranes is a prerequisite for viral entry into
cells and thus an essential step in the life cycle of all
enveloped viruses. The paramyxoviruses are enveloped
viruses encompassing mumps virus, measles virus, Sen-
dai virus, Newcastle disease virus, rinderpest virus, ca-
nine distemper virus, human parainfluenza viruses 1–4
and simian virus 5 (SV5) (reviewed in Lamb and Kolakof-
sky, 1996). SV5 contains two spike glycoproteins, the
hemagglutinin–neuraminidase protein (HN) and the fu-
sion protein (F) (Scheid and Choppin, 1974; Paterson et
al., 1984b, 1985). The HN protein is responsible for at-
tachment of the virion to its receptor, sialic acid, on the
target cell, whereas the F protein is directly involved in
virus-mediated membrane fusion at neutral pH.
The F protein of paramyxoviruses shares several fea-
tures with other viral membrane fusion proteins, includ-
ing Env of retroviruses, gp120/gp41 of human and simian
immunodeficiency viruses (HIV and SIV), and hemagglu-
tinin (HA) of influenza virus (reviewed in Hernandez et al.,
1996). The biologically active F protein consists of two
disulfide linked subunits, F1 and F2, that are generated
by proteolytic cleavage of a precursor polypeptide, F0
(Scheid and Choppin, 1974; Klenk and Garten, 1994).
Likewise, Env, gp120/gp41, and HA are proteolytically
activated by a host cell enzyme, leading to generation of
a membrane distal subunit and a membrane-anchored
subunit. In all cases the membrane-anchored subunit
contains a new N terminus that is hydrophobic and
highly conserved within virus families (reviewed in Wiley
and Skehel, 1987; Lamb, 1993; Hunter, 1997). This do-
main, called the fusion peptide, is known to insert into
the target membrane during the fusion process (Asano
and Asano, 1985; Novick and Hoekstra, 1988; Hernandez
et al., 1997; Damico et al., 1998). The paramyxovirus,
retrovirus, and influenza virus fusion glycoproteins are all
homotrimers (Wilson et al., 1981; Russell et al., 1994;
Fass et al., 1996a; Chan et al., 1997). Furthermore, each
glycoprotein contains a 4–3 heptad repeat adjacent to
the fusion peptide and a second 4–3 heptad repeat
adjacent to the presumptive transmembrane domain
(Chambers et al., 1990; Buckland et al., 1992). X-ray
crystallographic studies of a protease-resistant core of
influenza virus subunit HA2, a peptide derived from the
TM domain of Moloney murine leukemia virus (Mo-MLV),
and peptides corresponding to part of the TM subunit of
HIV gp41 demonstrated that these 4–3 heptad repeat
regions form triple-stranded coiled coils (Bullough et al.,
1 To whom correspondence should be addressed at Department of
Biochemistry, Molecular Biology and Cell Biology, Northwestern Uni-
versity, 2153 North Campus Drive, Evanston, IL 60208-3500. Fax: (847)
491-2467. E-mail: ralamb@nwu.edu.
VIROLOGY 248, 20–34 (1998)
ARTICLE NO. VY989242
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
20
1994; Fass et al., 1996b; Chan et al., 1997; Tan et al., 1997;
Weissenhorn et al., 1997).
A large body of evidence suggests that many viral
fusion proteins undergo a conformational change to be-
come fusion active (reviewed in Hernandez et al., 1996).
For influenza virus HA, the metastable cleaved native
form of HA undergoes, at the pH of fusion, a conforma-
tional change to form a more stable state in which the
previously buried fusion peptide is exposed and two
out-of-register a-helical regions rearrange to form a tri-
ple-stranded coiled coil with the fusion peptide at the
extremity of the coiled coil (Wilson et al., 1981; Carr and
Kim, 1993; Bullough et al., 1994). Although low pH natu-
rally triggers the conformational change (and fusion),
either increased temperature or urea can trigger the
conformational change in vitro (Ruigrok et al., 1986; Carr
et al., 1997). For the retrovirus Env glycoprotein and HIV
gp120/gp41, it is thought that binding to the viral receptor
induces a conformational change to release the fusion
peptide; in some cases, the membrane distal subunit is
also released (Moore et al., 1990; Hart et al., 1991; Her-
nandez et al., 1997; Damico et al., 1998). The highly
thermostable, helical, trimeric complex of a heptad re-
peat peptide from Moloney murine leukemia virus Env
TM domain and the highly thermostable, helical, trimeric
coiled coils of the peptides N36/C34 from HIV gp41 have
been suggested to represent the core most stable form
of these glycoproteins, which is likely an important struc-
tural component of the conformation of these proteins
that causes fusion or exists after fusion has been com-
pleted (Fass and Kim, 1995; Lu et al., 1995; Fass et al.,
1996b; Chan et al., 1997).
Although the 4–3 heptad repeats in influenza virus HA
or HIV gp41 are separated by a small number of resi-
dues, the heptad repeats in the membrane proximal F1
domain of the paramyxovirus fusion proteins are sepa-
rated by a large number of residues: One (HRA) abuts the
N-terminal fusion peptide and the second (HRB) is adja-
cent to the transmembrane domain (Fig. 1). For SV5, 270
residues separate the two heptad repeats. Nonetheless,
the two 4–3 heptad repeats are thought to be important
in the activity of the F protein, as point mutations in both
domains were found to interfere with the fusion activity of
the paramyxovirus F proteins (Buckland et al., 1992; Ser-
gel-German et al., 1994). Furthermore, insertions in the
eight-residue region between HRB and the presumptive
transmembrane domain abolish fusion activity (Zhou et
al., 1997). However, for paramyxoviruses both the nature
of the trigger and the presumptive conformational
change have not been identified conclusively (Lamb,
1993). Recent studies have demonstrated that isolated
peptides that overlap or are derived from these heptad
repeat regions of paramyxovirus F1 proteins (and also
the corresponding domains of HIV-1) display anti-viral
activity (Wild et al., 1992, 1994b; Jiang et al., 1993a,b; Lu
et al., 1995; Rapaport et al., 1995; Lambert et al., 1996; Yao
and Compans, 1996; Young et al., 1997; Munoz-Barroso
et al., 1998). The fusion inhibitory activity of these pep-
tides was suggested to be due to their ability to interact
with functional domains of the protein (Wild et al., 1994b).
To obtain further insights into the mechanism of
paramyxovirus mediated-membrane fusion, we synthe-
sized a series of peptides derived from the two heptad
repeat regions of the SV5 F protein. We have identified a
stable and helical structure consisting of a trimer of
heterodimers of two peptides, N-1 and C-1, correspond-
ing to the HRA and HRB regions of the SV5 F protein,
respectively. In addition, we show that the N-1 and C-1
peptides are potent inhibitors of fusion that inhibit the
fusion process at separate functionally defined stages.
RESULTS
Construction, expression, and purification of fusion
proteins
To characterize properties of the 4–3 heptad repeats
HRA and HRB of the SV5 F protein (Fig. 1A), peptides
corresponding to SV5 F protein residues 122–184 (N-1),
129–184 (N-2), 435–477 (C-1), and 453–477 (C-2) (Fig. 1A)
were produced in bacteria, fused to the C terminus of
glutathione S-transferase (GST) of Schistosoma japoni-
cum. The junction between GST and the peptides con-
tains a cleavage site for Factor Xa. Peptide N-1 contains
seven residues derived from the fusion peptide as well
as the complete HRA region, whereas peptide N-2 cor-
responds only to HRA. Peptides N-1 and N-2 both con-
tain a C-terminal tyrosine residue to facilitate determina-
tion of peptide concentration at A280. Peptides C-1 and
C-2 encompass the 4–3 heptad repeat B region (residues
453–477) of the F protein, with extra residues at the N
terminus present in C-1. GST-fusion proteins were over-
expressed in bacterial cells following IPTG induction and
affinity purified using glutathione-Sepharose beads. Pep-
tides were separated from GST protein by Factor Xa
digestion and purified to .95% homogeneity by reverse-
phase HPLC (Fig. 1B). The molecular masses of the
peptides were determined by mass spectroscopy to be
N1, 6426; N2, 5802; C1, 4611; and C2, 2630. These values
matched exactly the predicted masses.
N-1 and C-1 peptides form an a-helical complex
To examine the secondary structure of the peptides
N1, N2, C1, and C2, the circular dichroism (CD) spectra of
the peptides were measured from 193 to 300 nm. Peptide
N-1 (projected on a helical wheel plot in Fig. 2A) had a
CD spectrum exhibiting double minima at 208 and 222
nm under physiological conditions, characteristic of an
a-helix (Fig. 2C). The mean residual ellipticity at 222 nm
varied with concentration, suggesting that aggregation of
the peptide affected its structure. At a concentration of 10
mM, the 222-nm reading indicated that N-1 peptide has
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47% a-helical character (Fig. 2C). The N-1 peptide under-
went a thermal unfolding transition with an apparent Tm
of ;45°C (Fig. 2D), and this transition was irreversible,
presumably due to aggregation of unfolded peptides (Lu
et al., 1995). Peptide N-2 was also found to be a-helical
in nature (Fig. 2C), with 26% a-helical character at 10 mM
concentration, and it underwent a thermal unfolding sim-
ilar to N-1 peptide, with a Tm of ;45°C (data not shown).
Peptides C-1 and C-2 displayed little secondary structure
under physiological conditions (Fig. 2C), but they exhib-
ited significant a-helical content (;45 and 35%, respec-
tively) when examined in the helix-inducing environment
of 50% trifluoroethanol (Storrs et al., 1992) (data not
shown). The entire C-1 peptide is projected on a helical
FIG. 1. (A) Schematic diagram of the fusion protein of the paramyxovirus SV5 and the amino acid sequences of the peptides used. The N-terminal
signal sequence (SP), the proteolytic cleavage-activation site (C), the fusion peptide (FP), heptad repeat A (HRA), heptad repeat B (HRB), and the
presumptive transmembrane domain (TM) are indicated. F2 is disulfide linked to the membrane bound segment F1. The sequences of the peptides
N-1, N-2, C-1, and C-2 are indicated. N-1 and N-2 contained a C-terminal tyrosine residue not found in the native protein to facilitate peptide
concentration measurements. (B) Tricine–SDS–gel electrophoresis of purified peptides. To determine the purity and apparent molecular weights of
the peptides, aliquots of HPLC-purified peptides were subjected to Tricine–SDS–gel, electrophoresis. The sizes of protein molecular weight markers
(kDa) are indicated at the left. The molecular masses of the peptides N-1, C-1, and C-2 as determined by mass spectroscopy were 6426, 4611, and
2630, respectively.
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wheel plot in Fig. 2B although peptide C-1 is larger than
the predicted 4–3 heptad repeat (residues 453–477). As
peptides C-1 and C-2 are unfolded, they do not undergo
thermal unfolding (Fig. 2D and data not shown). The CD
spectrum of an equimolar mixture of the N-1 and C-1
peptides indicated a high helical content (;82%) (Fig.
3A). The spectrum differed demonstrably from the pre-
dicted spectrum for noninteracting peptides (added
spectrum of individual peptides) (data not shown), indi-
cating that the peptides form an a-helical complex. The
N-1 1 C-1 complex was extremely stable, unfolding
irreversibly with a Tm .90°C (Fig. 3B). The CD spectrum
of an equimolar mixture of N-1 and C-2 peptides was
observed to be less a-helical (68%), with minima shifted
slightly from that expected for a model a-helix (Fig. 3A),
and it was less stable than the N-1 1 C-1 peptide
FIG. 2. (A) The sequence of the N-1 peptide as projected onto a helical wheel. The view is from the N terminus. (B) The sequence of the C-1 peptide
as projected onto a helical wheel, as in (A). Note that peptide C-1 is larger than the predicted 4–3 heptad repeat [residues 453–477]. (C) The CD
spectra for the individual purified N-1, N-2, C-1, and C-2 peptides (10 mM) in PBS at 2°C. (D) Temperature dependence of the CD signal at 222 nm
for N-1 and C-1 peptides (1 mM) in PBS.
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complex, unfolding irreversibly with a Tm .65°C (Fig.
3B). It was observed that the melting profile of the N1 1
C2 peptide complex was biphasic, suggesting separate
unfolding of different parts of the complex. As peptide N2
showed a tendency to aggregate, its association with
C-1 and C-2 was not examined.
The peptide complex is a trimer of heterodimers
Peptides that form a complex often become resistant
to protease digestion. Therefore, the sensitivity of the
peptides N-1, C-1, and C-2 and the complexes N-1 1 C-1
and N-1 1 C-2 to proteinase K was determined. The
peptides were incubated with proteinase K, the digestion
was stopped with PMSF, the samples were heated in 2%
SDS at either 40 or 100°C, the peptides were subjected
to electrophoresis on SDS–Tricine gels, and the peptides
were stained with Coomassie brilliant blue. On the gel
system used, it was observed that peptide N-1 often
migrated as a doublet even though mass spectroscopic
analysis of N-1 peptide indicated only one species (mass
6426) (Fig. 4). The N-1 peptide was trimmed by protein-
ase K digestion at 4°C, and the appearance of slower
mobility species suggested that the proteinase K
trimmed N-1 peptide has a tendency to form oligomers
which are resistant to SDS denaturation at 40°C. Repu-
rification of trimmed N-1 by HPLC, followed by analysis
by mass spectroscopy, indicated that trimmed N-1 had a
mass of 5594, which corresponds to an N-1 peptide with
four amino acids lost from its C terminus and five amino
acids lost from its N terminus. Peptide C-1 was protein-
ase K sensitive and peptide C-2 was largely sensitive to
proteinase K digestion.
When the peptides N-1 and C-1 were mixed in equimo-
lar amounts and heated to 40°C in 2% SDS, the majority
of the peptide migrated as a higher molecular weight
species, Mr 27,000. This SDS-resistant species was
trimmed to a protease-resistant species of Mr 20,000
after digestion with proteinase K at 4°C and heating to
40°C in 2% SDS. When the proteinase K-treated N-1 1
C-1 complex was heated to 100°C, the complex dissoci-
ated, yielding a predominant trimmed N-1 species. The
vast majority of peptide C-1 was lost, although in some
experiments small amounts of species Mr 4000 and 3700
were observed, which are presumably derived from the
C-1 peptide. The proteinase K-treated N-1 1 C-1 com-
plex was repurified on HPLC and peptides were ana-
lyzed by mass spectroscopy. The trimmed N-1 peptide
had a mass of 6149, indicating that two residues were
removed from the N-1 C terminus. Thus, peptides C-1
and N-1 form a complex which is resistant to 2% SDS
dissociation at 40°C and in which the N-1 peptide is
further stabilized by its association with C-1 prior to
proteinase K digestion. The C-1 peptide in the complex is
FIG. 3. (A) The CD spectrum of N-1 (10 mM) 1 C-1 (10 mM) complex, N-1 (10 mM) 1 C-2 (10 mM) complex, and isolated N-1, C-1, and C-2 peptides
in PBS at 2°C. (B) Thermal dependence of the CD signal at 222 nm of N-1 1 C-1 and N-1 1 C-2 complexes in PBS.
FIG. 4. Proteinase K digestion of individual peptides (N-1, C-1 and
C-2) and peptide complexes (N-1 1 C-1 and N-1 1 C-2). N-1 peptide
(70 mM) was preincubated with or without equimolar amounts of either
C-1 or C-2 peptides, and the peptides were subjected to proteinase K
digestion as described under Materials and Methods. The samples
were subjected to heating in protein lysis buffer either at 40°C or at
100°C prior to SDS–PAGE on tricine gels. Polypeptides were stained
with Coomassie brilliant blue. The sizes of sets of protein molecular
weight markers (kDa) are indicated on both sides of the gel.
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nonetheless almost completely sensitive to protease di-
gestion. A high molecular weight oligomeric complex
was not observed when peptides N-1 and C-2 were
mixed in equimolar amounts and treated with 2% SDS at
40°C. However, the N-1 1 C-2 complex was resistant to
proteolytic digestion with the exception of the trimming
of the N-1 peptide (Fig. 4). HPLC repurification of the
proteinase K treated N-1 1 C-2 complex and mass spec-
troscopy indicated that peptide C-2 was completely pro-
tected from digestion. The major species of trimmed N-1
peptide had a mass of 5595, corresponding to a loss of
four residues from the N-1 C terminus and five residues
from the N-1 N terminus, identical to the N-1 trimmed
species found after proteinase K treatment of N-1 pep-
tide alone.
To further investigate the nature of the peptide com-
plexes, sedimentation equilibrium centrifugation experi-
ments were performed to determine the masses of the
complexes by a method other than mobility on SDS–
PAGE. Sedimentation equilibrium centrifugation of the
N-1 1 C-1 complex at multiple concentrations yielded a
mass of 31,300 Mr (calculated mass of N-1 1 C-1 as a
trimer is 33,111), indicating that the complex consists of
three molecules each of N-1 and C-1 (Fig. 5C). This
finding is consistent with the observation from chemical
cross-linking data that the native F protein is trimeric
(Russell et al., 1994). The mass of the proteinase K
treated N-1 1 C-1 complex was determined to be 18,900
Mr (Fig. 5D), consistent with the conclusion that peptide
C-1 is sensitive to digestion by proteinase K even after
forming a complex with peptide N-1 (see Fig. 4). Equilib-
rium centrifugation of the N-1 peptide alone yielded a
mass of 16,000 Mr (calculated mass of N-1 homotrimer is
19,278) (Fig. 5A). However, the formation of oligomers by
the N-1 peptide was observed to be concentration de-
pendent: oligomeric species were formed only above a
FIG. 5. Equilibrium centrifugation of peptides and peptide complexes. N-1 peptide alone (A), proteinase K-treated N-1 peptide (B), N-1 1 C-1
complex (C), and proteinase K-treated N-1 1 C-1 complex (D). Peptides at concentrations of 20, 50, and 100 mM in PBS were subjected to equilibrium
centrifugation at 4°C and the absorbance was scanned at 237 and 280 nm. In each panel, the distribution of fit residuals is shown at the top and
the data (plotted as solute absorbance versus radial distance) fitted to the theoretical curve (solid line) are shown at the bottom. Sedimentation is
from left to right. The mass of N-1 was determined to be 16,000, whereas the mass of N-1 monomer by mass spectroscopy is 6426. However, it was
observed that the observed mass of N-1 was concentration dependent and the peptide had a tendency to aggregate; thus the oligomeric form of N-1
could not be determined. The mass of the proteinase K treated N-1 peptide was determined to be 17,200, and the mass of the trimmed peptide as
determined by mass spectrometry was 5595, indicating proteinase K trimmed N-1 forms a trimeric complex. The mass of the N-1 1 C-1 complex was
determined to be 31,300 and the theoretical mass of a trimer of N-1 1 C-1 heterodimers ([6,426 1 4,611] 3 3) is 33,111, indicating the complex is
trimeric. The determined mass of the proteinase K treated N-1 1 C-1 peptide complex was determined to be 18,900, which is consistent with the
observation shown in Fig. 4 and (B) that after proteinase K digestion, N-1 is trimeric and protease resistant whereas most, but not all, of C-1 is
susceptible to proteinase K digestion.
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concentration of 20 mM N-1 peptide. In contrast, the
molecular mass of proteinase K-treated N-1 peptide was
determined to be 17,200 Mr (calculated mass 16,782), a
value that was unaffected by peptide concentration, sug-
gesting the formation of a trimer by this peptide after
proteinase K digestion (Fig. 5B).
Inhibition of F-protein-mediated cell fusion by
peptides
The relative abilities of the HRA and HRB related
peptides to inhibit cell fusion mediated by the SV5 F
protein were examined. As cell fusion involves both the
mixing of the outer leaflet membrane lipids and the
mixing of inner leaflet membrane lipids with concomitant
mixing of aqueous contents of donor and recipient cells,
we examined the effect of peptides on both lipid mixing
and content mixing activity of the F protein.
Inhibition of aqueous continuity by peptides
We employed the reporter gene (b-galactosidase) ac-
tivation assay to measure the content mixing potential of
the F protein in the presence or absence of peptides and
their complexes. The C-1 peptide was found to be a very
effective inhibitor (IC50 ; 6 mg/ml) of content mixing.
Peptides N-1 and N-2 were substantially less active (IC50
of ;18 and 16 mg/ml, respectively) (Fig. 6), but they could
inhibit content mixing completely at concentrations
above 50 mg/ml. Peptide C-2 did not exhibit a significant
effect on the content mixing activity of F protein, with only
25% inhibition observed even at very high concentrations
(75 mg/ml). When peptides N-1 and C-1 were mixed in
equimolar amounts, the complex inhibited content mix-
ing with an IC50 20 mg/ml, suggesting that the presence
of the N-1 peptide modifies the potent inhibitory activity
of C-1 peptide, presumably by formation of the peptide
complex. Thus, all the peptides were found to inhibit the
content mixing activity of the F protein, although to vary-
ing extents. The effects of the peptides on fusion pro-
moted by the wild-type F protein or by an F protein
containing a mutation in the fusion peptide (F-G3A),
which increases the rate and extent of cell fusion (Hor-
vath and Lamb, 1992; Bagai and Lamb, 1997), were iden-
tical (Fig. 7). The inhibition of content mixing by peptides
was highly specific for SV5 and no cross inhibitory ac-
tivity of any of the peptides was detected for content
mixing mediated by the F proteins of the paramyxovi-
ruses HPIV-3 and NDV F even at very high concentra-
tions (100 mg/ml) (Fig. 7).
Effect of peptides on lipid mixing activity of SV5 F
protein
To examine lipid mixing promoted by the SV5 F pro-
tein, we compared the spread of the lipophilic probe R18
between RBCs and cells expressing the SV5 F and HN
FIG. 6. The heptad repeat peptides inhibit fusion. The dose response of the inhibition of aqueous content mixing of the N-1, N-2, C-1, C-2 peptides
and an equimolar mixture of N-1 and C-1 peptides is shown. b-Galactosidase activity was detected using the gene reporter assay as described under
Materials and Methods. Each data point represents the average of three experiments.
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proteins in the presence and absence of peptides (and
peptide complexes), using confocal microscopy. The
R18-labeled RBCs were bound to the cells expressing
the SV5 envelope proteins in the absence or presence of
varying concentrations of peptides (10 to 100 mg/ml) at
4°C. Following incubation at 37°C for 15 min, the cells
were observed by confocal microscopy. Peptide C-1 in-
hibited the dye transfer from labeled RBCs to cells ex-
pressing SV5 envelope proteins at a concentration as
low as 10 mg/ml, and the extent of inhibition at various
concentrations of peptide was found to be very similar to
that found in the content mixing assay. In contrast, pep-
tides N-1 and N-2 did not inhibit dye transfer even at
concentrations as high as 100 mg/ml, a concentration
two times the level needed to cause complete inhibition
of content mixing. The peptide mixture of equimolar
amounts of N-1 1 C-1 also did not inhibit F-protein-
promoted lipid mixing (Fig. 8). Thus, the N-1 and N-2
peptides do not prevent the F protein from causing hemi-
fusion but do inhibit cytoplasmic content mixing, thus
defining functionally different steps in the fusion process.
DISCUSSION
The recently obtained three-dimensional structures of
portions of the HIV gp41 protein (Chan et al., 1997; Tan et
al., 1997; Weissenhorn et al., 1997) and a fragment of the
Moloney murine leukemia virus transmembrane (TM)
protein (Fass et al., 1996b) have confirmed a structural
model for retroviral fusion proteins, in which regions
corresponding to the SV5 F protein heptad repeat A form
an interior, trimeric coiled coil associated with three
surrounding heptad repeat B regions aligned in an anti-
parallel orientation (Blacklow et al., 1995; Lu et al., 1995).
Significantly, the structure of this retroviral core domain
has striking similarities to the low pH-induced HA2 struc-
ture (Bullough et al., 1994). The analysis presented here
of synthetic peptides corresponding to the two heptad
repeat regions of the SV5 F protein suggests that the
fusion proteins of the paramyxovirus family can form a
similar structure, strengthening the hypothesis of a con-
served paradigm for fusion promotion among fusion pro-
teins from widely disparate viruses (Hughson, 1997).
Peptides corresponding to the HRA region of the SV5
F protein (N-1 and N-2) were found to be partially a-he-
lical in character, with peptide N-1, which contains an
additional seven residues from the fusion peptide region,
found to be twice as helical in nature as the N-2 peptide
(Fig. 2A). This suggests that the presence of a portion of
the fusion peptide serves to stabilize HRA in a helical
form. The majority of the isolated N-1 peptide was found
to be protease resistant (Fig. 4), and the protease-resis-
tant portion was demonstrated to form stable trimers
(Fig. 5B), indicating that the HRA region of the F protein
can interact to form a core unit. The trimeric associations
of analogous regions of MoMLV TM, HIV gp41, and the
low pH-induced form of influenza virus HA have been
observed in the X-ray structures (Bullough et al., 1994;
Chan et al., 1997; Tan et al., 1997; Weissenhorn et al.,
1997). However, the isolated N-terminal heptad repeats
have been found to form a trimeric, protease-resistant
core, as demonstrated here for the SV5 F protein, only in
the case of MoMLV (Fass and Kim, 1995) but not for
either HIV or SIV gp41 (Blacklow et al., 1995; Lu et al.,
1995), suggesting that the stability of the N-terminal hep-
tad repeat core trimer varies considerably between viral
fusion proteins.
Addition of peptides corresponding to the HRB region
of the SV5 F protein (C-1 or C-2) to the N-1 peptide
results in complexes with increased helical character
(Fig. 3A). The complex formed by N-1 and C-1 is ex-
tremely stable to heat denaturation (Fig 3B), and analysis
by sedimentation equilibrium centrifugation indicates
that the peptides are present in the complex as 3(C-1 1
N-1) (Fig. 5C). Interestingly, only the N-1 peptide in the
FIG. 7. Specificity of heptad repeat peptides (shown for C-1) against
homologous and heterologous paramyxovirus fusion proteins. One
culture of CV-1 cells was infected with recombinant vaccinia virus
vTF7–3, which encodes T7 RNA polymerase, and cotransfected with
plasmid DNA encoding the cDNAs for the NDV or HPIV3 F and HN
proteins or SV5 HN and wt F or the SV5 fusion peptide mutant F-G3A
proteins. A second culture of CV-1 cells was infected with wt vaccinia
virus (strain WR) and transfected with plasmid pGINT7b-gal, which
encodes b-galactosidase. Mixtures of the two populations of cells (0.1
ml each) were plated in triplicate in 96-well plates and incubated at
37°C for 4 h in either the absence or the presence of 75 mg/ml of C-1
peptide. Samples were analyzed by the colorimetric lysate assay as
described under Materials and Methods. Each point represents an
average of three experiments. 1P indicates addition of SV5 C-1 peptide
to a fusion assay of the indicated paramyxovirus F and HN proteins.
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complex is resistant to protease treatment, indicating
that the N-1 peptide resides in the interior of the com-
plex. The complex of N-1 with the smaller C-2 peptide,
which contains only the residues of the HRB region, is
less stable than the N-1 1 C-1 complex, as judged by
thermal denaturation (Fig. 3B). However, the C-2 peptide
in the N-1 1 C-2 complex is completely resistant to
protease digestion, suggesting that portions of C-1 that
correspond to regions outside the HRB region are re-
sponsible for its protease sensitivity within the N-1 1 C-1
complex.
Heptad repeat regions are characterized by the pres-
ence of hydrophobic residues at their a and d positions.
An examination of the residues in the heptad repeat
regions of the SV5 F protein reveals that the e and g
residues of the N-terminal heptad repeat are also pri-
marily nonpolar, unlike the e and g residues of the
C-terminal heptad repeat, which are mainly polar and
include sites known to be modified by addition of N-
linked carbohydrate. This paradigm is conserved among
all paramyxovirus F proteins examined (Fig. 9A), sug-
gesting an important functional role for the HRA e and g
hydrophobic residues. We propose that, like the arrange-
ment in HIV and SIV gp41 (Blacklow et al., 1995; Lu et al.,
1995), N-1 and C-1 form a six-stranded helical bundle in
which the highly conserved, mostly hydrophobic resi-
dues at the a and d heptad positions of the N-1 helices
pack together at the core of a three-stranded coiled coil.
The nonpolar e and g residues of adjacent N-1 strands
are then buried in the interior of the complex, packed
against the hydrophobic a and d residues of the sur-
rounding C-1 strands (Fig. 9B).
Synthetic peptides that contain the N- and C-terminal
heptad repeat regions of HIV gp41 have been found to be
potent inhibitors of HIV-1 infection and syncytia formation
(Wild et al., 1992, 1994b; Jiang et al., 1993a,b; Nehete et
al., 1993; Slepushkin et al., 1993; Judice et al., 1997; Lu et
al., 1995; Munoz-Barroso et al., 1998). In addition, pep-
FIG. 8. Inhibitory effect of N-1, C-1, and C-2 peptides and equimolar amounts of N-1 and C-1 peptides on fusion as detected by the R18 dye trasfer
assay. RBCs labeled with R18 were bound to CV-1 cells coexpressing SV5 F and HN proteins in the presence or absence of different peptides (100
mM) and fusion was triggered by shifting incubation to 37°C. The distribution of dye was monitored after 15 min by confocal microscopy using
appropriate filters.
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tides derived from the conserved heptad repeat domains
of paramyxovirus F proteins have been shown to pos-
sess anti-viral activity (Rapaport et al., 1995; Lambert et
al., 1996; Yao and Compans, 1996; Young et al., 1997). We
have studied the effects of peptides N-1, N-2, C-1, and
C-2 on SV5 F-protein-mediated cell fusion. All peptides
examined were found to be inhibitory to the final stage of
F-protein-promoted fusion, the mixing of cytoplasmic
contents, with the C-1 peptide effective at much lower
concentrations than either N-1 or N-2. However, only the
C-1 peptide was found to inhibit lipid-mixing, with the N-1
and N-2 peptides demonstrating no effect on this stage
of fusion even at concentrations twice that required for
complete inhibition of content mixing by these peptides.
Hemifusion is a presumptive intermediate event in the
fusion process, in which the outer but not the inner
leaflets of two fusing membranes have merged, without
the mixing of their aqueous contents (Chernomordik et
al., 1997). The N-terminal peptides therefore do not pre-
vent the F protein from promoting hemifusion but do
prevent complete fusion with the target cells from occur-
ring. Thus, the inhibition by the N and C peptides delin-
eates two different steps in the pathway of F-protein-
promoted fusion. Interestingly, inhibition of fusion by C-1
is markedly reduced when stoichiometric amounts of N-1
are also present, with the fusion inhibition seen with the
FIG. 9. (A) Sequence homology of the F protein heptad repeat A and B regions in different paramyxovirus F proteins. Amino acids at positions a,
d, e, and g of heptad repeats are shown. Red indicates identical residues, residues of similar properties are shown in black, and dissimilar residues
are shown in green (glycine by default is shown as a dissimilar residue). MPV, mumps virus, NDV, Newcastle disease virus, SV, Sendai virus, MV,
measles virus. Amino acid sequences of the F proteins were obtained from the GenBank database. (B) Model for the putative a-helical trimer of
heterodimers formed by the N-1 and C-1 peptides in the SV5 F protein F1 subunit, depicting possible hydrophobic interactions between amino acids
at positions a and d of adjacent N-1 helices and between amino acids at positions a and d of single C-1 helices and positions e and g of adjacent
N-1 helices.
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N-1 1 C-1 complex similar to that seen for the N-1
peptide alone.
It has been suggested that the inhibitory effect of
synthetic peptides is related to their ability to interact
with the complementary portions of the F or gp41 protein
(Jiang et al., 1993a; Wild et al., 1994a; Lambert et al.,
1996), likely preventing formation of the six-helical bun-
dle required for fusion (Blacklow et al., 1995; Lu et al.,
1995). As the C-1 peptide clearly acts earlier in the fusion
cascade than the N-1 peptide, we suggest that the C-1
peptide interacts with the HRA region on the F protein to
prevent either the initial putative conformational change
or a change to an intermediate form required for hemi-
fusion. Subsequently, interaction of the N-1 peptide with
the HRB domain on the F protein would prevent forma-
tion of the six-helical bundle and complete fusion. Alter-
natively, it is possible that formation of the six-helical
bundle is required for hemifusion. In this scenario, the
C-1 peptide is suggested to interact with the HRA region
on the protein to prevent formation of the six-helical
bundle, with the N-1 peptide acting at a later stage. It has
recently been demonstrated that differential effects on
fusion are found with peptides corresponding to the two
heptad repeats of gp41 (Munoz-Barroso et al., 1998),
though intriguingly, in this case it is the C-terminal pep-
tide which blocks only after hemifusion. It was suggested
that the block after hemifusion occurs because the pep-
tides prevent the separation of fusion protein trimers
needed to allow opening of the fusion pore (Munoz-
Barroso et al., 1998).
The data presented here show that peptides corre-
sponding to the N- and C-terminal heptad repeat regions
of the SV5 F protein can exist as a stable six-helical
bundle and that the presence of these peptides can
prevent promotion of fusion by the F protein. Therefore,
we suggest that 3(C-1 1 N-1) represents the core of the
final, most stable form of the SV5 F protein, present either
during or subsequent to promotion of membrane fusion
(Fig. 10). The possibility that a third heptad repeat found
in paramyxovirus F proteins (Sendai virus residues 269–
301) (Ghosh et al., 1997) associates with the N1 1 C1
trimer of heterodimers has not been investigated. It has
been widely speculated that the paramyxovirus F pro-
teins undergo a conformational rearrangement to re-
lease the hydrophobic fusion peptide, though the trigger
for this putative conformational change is not known
(Lamb, 1993). Both the analogy to the influenza HA pro-
tein and the inhibitory effects of the isolated peptides
suggest that the six-helical bundle is not present in the
native state of the F protein but forms at some point
during the fusion process after the initial conformational
change. In the model (Fig. 10), the N-1 and C-1 helices
are depicted in an anti-parallel fashion, but the data
obtained to date do not establish the orientation of the F
protein helices relative to each other. Electron micro-
scopic examination of influenza HA has indicated that
the fusion peptide and TM domains reside close to-
gether in the same membrane after completion of mem-
brane fusion (Wharton et al., 1995), as would be expected
with an antiparallel orientation of helices. In addition, the
X-ray structures of influenza virus HA, MoMLV TM, and
HIV gp41 all reveal an antiparallel orientation of helices
in the central core (Bullough et al., 1994; Fass and Kim,
1995; Chan et al., 1997; Tan et al., 1997; Weissenhorn et
al., 1997). The antiparallel configuration seems the most
logical structure, as a parallel orientation of the HRA and
HRB helices would place the fusion peptide and the
transmembrane domain of the F protein on opposite
ends of the helical core, though they are both expected
FIG. 10. Model of the N 1 C complex. Schematic diagram showing
the N-1 peptide in the center as a trimeric coiled coil structure against
which are packed three C-1 peptide helices. The N-1 and C-1 peptides
are shown as antiparallel based on logical argument (see Discussion)
and by analogy to the structures of influenza virus HA and HIV-1 gp41
helices. However, the N-1 and C-1 peptides could consist of parallel
helices, in which case the C-1 peptide would be inverted: the orienta-
tion of the helices remains to be formally determined. The fusion
peptides are shown to be exposed in this model (red) and the remain-
der of the large domain (252 amino acids) of the F1 subunit between
N-1 the C-1 helices is shown as a loop.
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to reside in membranes. In addition, in a parallel orien-
tation scenario residues from the large intervening re-
gion between HRA and HRB regions would be present
near both the fusion peptide and TM domains. Further
experiments, however, will be needed to confirm the
orientation of the helices in our model.
MATERIALS AND METHODS
Cells and recombinant plasmid vectors
Monolayer cultures of the TC7 subclone of CV-1 cells
were grown in Dulbecco’s modified Eagle’s medium
(DMEM) containing 10% NU Serum IV (Collaborative Re-
search Laboratories, Inc., Bedford, MA) as described
previously (Paterson et al., 1985). The plasmids pGEM2X-
SV5 F and pGEM3X-SV5 HN containing the SV5 F and
HN cDNAs were described previously (Bagai and Lamb,
1995; Paterson et al., 1984a). The plasmid pGINT7 b-gal
(Nussbaum et al., 1994) containing the b-galactosidase
cDNA was kindly provided by Drs. Edward Berger and
Bernard Moss (National Institutes of Health, Bethesda,
MD). All cDNAs were cloned in pGEM2X in an orientation
such that mRNA–sense RNA transcripts could be syn-
thesized by using bacteriophage T7 RNA polymerase.
Construction of plasmids
pGEM2X-SV5 F was used as the template to amplify
the regions in the F gene corresponding to amino acid
residues 122–184, 129–184, 435–477, and 453–477 by
standard PCR methods and use of synthetic oligonucle-
otides. The primers were designed to introduce an up-
stream BamHI site and a downstream SalI site into the
amplified fragment, as well as a Factor Xa protease
recognition site immediately following the BamHI site
and a stop codon preceding the SalI site. A tyrosine
codon was also introduced preceding the stop codon in
the two peptides derived from the HRA region to facilitate
the determination of peptide concentration by absor-
bance at 280 nm. The amplified fragments were subse-
quently cloned into the BamHI–SalI sites of the vector,
pGEX-4T-1, from which proteins or peptides can be ex-
pressed as fusion proteins with Schistosoma japonicum
glutathione S-transferase (Frangioni and Ne´el, 1993). All
insert sequences were confirmed by DNA sequencing
using an ABI 310 genetic analyzer (Perkin–Elmer, Foster
City, CA).
Protein expression and purification
Plasmids were transformed into Escherichia coli DH1
cells. Bacterial cells were grown at 37°C to middle al-
gorithmic phase (optical density at 600 nm of 0.8 to 1.00)
in Luria–Bertani medium. Protein expression was then
induced with IPTG (0.1 mM), and cells were harvested
after a 3-h incubation period. Cells were lysed by soni-
cation (Branson sonifier 450, VWR Scientific) for 90 s in
phosphate-buffered saline (PBS, 10 mM sodium phos-
phate, pH 7, 150 mM NaCl) containing a cocktail of
protease inhibitors (Paterson and Lamb, 1993), and Tri-
ton X-100 (final concentration 2%) was then added to the
cell lysate. Following incubation at 4°C for 1 h, the lysate
was clarified by centrifugation at 12,000 g for 20 min at
4°C. Two milliliters of glutathione–Sepharose beads
(50% v/v in PBS) was added to each 100 ml supernatant
obtained after centrifugation and incubated overnight at
4°C with gentle rocking.
Factor Xa cleavage of fusion protein
The GST-fusion protein-bound matrix was washed
three times with PBS containing Triton X-100 (2% final
concentration) followed by two washes with Factor Xa
cleavage buffer (50 mM Tris–HCl, pH-7.5, 150 mM NaCl,
1 mM CaCl2). Factor Xa was added (50 mg Factor Xa/ml
glutathione–Sepharose beads) to the glutathione–
Sepharose pellet in 1 ml cleavage buffer and incubated
for 6–8 h at 4°C. The suspension was then centrifuged at
500 g for 5 min to pellet the beads, and the eluate
containing the peptides was removed carefully. Peptides
were then purified to homogeneity by reverse-phase
HPLC (Hewlett Packard, series 1090), using a Vydac C-4
preparative column and a linear gradient of acetonitrile
containing 0.09% trifluoroacetic acid. Peptides were
dried under vacuum for 12 h and dissolved in PBS.
Peptide concentration was determined spectrophoto-
metrically at A280 (Gill and von Hippel, 1989).
CD spectroscopy
CD spectra were recorded on a Jasco J-715 spectro-
photometer (Jasco Inc., Tokyo, Japan) equipped with a
thermoelectric temperature controller. The cuvettes used
for thermal unfolding studies and for wavelength spectra
were 1 and 0.1 cm in path length, respectively. CD spec-
tra were recorded at 2°C using a 10 mM sample of
peptides in PBS buffer. Thermodynamic stability was
measured at 222 nm by monitoring the CD signal in the
range 10–98°C with a scan rate of 1°C per minute using
1 mM peptides sample in PBS. The percentage helicity
for peptides was calculated as described previously
(Scholtz et al., 1991).
Proteolysis protection experiments
Peptides N-1 and either C-1 or C-2 were mixed in
equimolar amounts (70 mM each) and incubated at room
temperature for 1 h. The peptide complexes were then
subjected to proteolysis with proteinase K (Boehringer
Mannheim, Indianapolis, IN) (1% wt/wt, proteinase
K/peptide) at 4°C for 2 h in PBS buffer. Proteolysis was
stopped by addition of phenylmethylsulphonyl fluoride
(PMSF) (Sigma Chemical Co., St. Louis, MO) to a final
concentration of 5 mM with further incubation at room
temperature for 20 min. The digestion products were
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analyzed by Tricine–SDS–gel electrophoresis (Schagger
and Von Jagow, 1987) and stained with Coomassie bril-
liant blue.
Analytical ultracentrifugation
Sedimentation equilibrium measurements were per-
formed at 4°C on an Optima XLA analytical centrifuge
(Beckman Instruments, Palo Alto, CA) using an An-Ti
rotor and six-sectored equilibrium centrifugation center-
pieces. To determine the molecular weights of N-1 pep-
tide and N-1 1 C-1 peptide complex either treated or
untreated with proteinase K, rotor speeds of 32,000 and
25,000 rpm, respectively, were used. Meniscus depletion
(to obtain a baseline) was performed at 42,000 rpm.
Samples of 100 mM peptide or peptide complex were
prepared in PBS and were dialyzed against the same
buffer. Three dilutions of each sample (20, 50, and 100
mM) were prepared by dilution with dialysate, and dialy-
sate was also used to fill the reference cells. The appar-
ent molecular weights were calculated by fitting the data
to a single ideal species model using the software pro-
gram XLA (Beckman Instruments). Partial specific vol-
umes of 0.755 for N-1 and 0.757 for C-1 were calculated
by averaging the specific volumes of the amino acids
(Schuster and Laue, 1994).
Mass spectroscopy
Peptides (N-1 1 C-1 or N-1 1 C-2) were incubated in
equimolar amounts for 1 h at room temperature and
treated with 1% proteinase K at 4°C for 2 h in PBS.
Proteolysis was stopped by addition of PMSF as de-
scribed above. The proteolytic fragments were sepa-
rated and purified by HPLC and characterized by mass
spectroscopy (Micromass Quattro II triple stage quadru-
pole mass spectrometer, Micromass Inc., Beverly, MA).
Labeling of human erythrocytes with octadecyl
rhodamine B
Human erythrocytes (RBCs) were labeled with the lipid
probe octadecyl rhodamine B (R18) (Molecular Probes,
Eugene, OR) as described (Morris et al., 1989; Bagai and
Lamb, 1995). Fifteen microliters of R18 (1 mg/ml in etha-
nol) was rapidly added to human RBCs (1% hematocrit in
10 ml PBS) by using a Hamilton syringe. After incubation
at room temperature for 15 min, 30 ml of DMEM supple-
mented with 10% NU serum IV was added to the sus-
pension to absorb unbound probe. The RBCs were fur-
ther incubated for 20 min at room temperature and
washed six times by centrifugation with 50 ml PBS.
Cell fusion inhibition assays
The ability of peptides to inhibit virus-mediated cell–
cell fusion was assessed by both lipid mixing and con-
tent mixing cell fusion assays.
Vaccinia virus based expression of foreign genes
Transient expression of the paramyxovirus envelope
proteins (F and HN of SV5, Newcastle disease virus, and
human parainfluenza virus 3) in CV-1 cells was per-
formed as described previously (Fuerst et al., 1986; Bagai
and Lamb, 1995). Nearly confluent monolayers of cells
grown on 60-mm plastic dishes were infected with re-
combinant vaccinia virus v-TF7.3, which expresses T7
RNA polymerase, at an m.o.i. of 10 PFU/cell and then
incubated at 37°C for 45 min. The virus inoculum was
removed and cells were washed twice with OPTI-MEM
(GIBCO/BRL, Gaithersburg, MD) and transfected with
plasmid DNAs using cationic liposomes prepared as
described (Rose et al., 1991). Typically 5.0 mg of plasmid
DNA was used for a 60-mm tissue culture dish and the
volume adjusted to 2.0 ml with OPTI-MEM (GIBCO BRL,
Gaithersburg, MD). At 5 h posttransfection cells were
washed twice in PBS and further treated for fusion
assays.
Lipid mixing analysis: Confocal microscopy
CV-1 cells grown on cover slips and expressing SV5 F
and HN proteins at 5 h posttransfection were washed
twice and incubated overnight at 32°C in DMEM con-
taining 10% NU serum IV. The cells were washed with
PBS, incubated for 1 h at 37°C with 50 mU/ml of neur-
aminidase (Vibrio cholerae) (Boehringer Mannheim) in
DMEM, and washed twice with PBS. Three milliliters of
R18-labeled RBCs (0.1% hematocrit) in PBS was added to
the monolayer in the presence or absence of various
concentrations of peptides and incubated at 4°C for 30
min with occasional gentle agitation. Unbound RBCs
were removed by six washes with PBS. Fusion was
triggered by transfer of the coverslips to 37°C for 15 min.
The coverslips were then placed on microscope slides
and cells photographed with a confocal microscope
(LSM 410, Zeiss Inc, Thornwood, NY). R18 fluorescence
was visualized under a ‘‘rhodamine’’ filter set.
Content mixing assay
The content mixing assay based on the cytoplasmic
activation of the reporter gene b-galactosidase was per-
formed essentially as described (Nussbaum et al., 1994)
with slight modifications (Bagai and Lamb, 1996). The
cells expressing T7 RNA polymerase and paramyxovirus
homotypic F and HN proteins at 5 h posttransfection
were trypsinized, suspended in DMEM containing 2.5%
NU serum IV to a density of 2 3 105/ml, and incubated
overnight at 32°C in a near horizontal position. The cells
were washed twice in OPTI-MEM (containing 2.5 mM
CaCl2), suspended to a density of 2 3 10
7/ml, and treated
with neuraminidase (50 mU/ml) for 1 h at 37°C. The cells
were then washed and suspended in OPTI-MEM at 106
cells/ml. A second population of CV-1 cells was infected
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with wt vaccinia virus (strain WR) for 45 min at 37°C and
transfected with plasmid pGINT7 b-gal. At 5 h posttrans-
fection, cells were washed and incubated overnight as
described above. The cells were then washed with OPTI-
MEM. The two cell populations were mixed by addition
of 100 ml of each cell population in a 96-well tissue
culture plate in the presence or absence of various
concentrations of peptides, with each sample tested in
triplicate. When two different peptides were used in
combination, they were incubated together for 1 h prior
to addition of the cell populations. The plates were incu-
bated at 37°C for 4 h, and cell fusion was measured by
using a colorimetric lysate assay for b-galactosidase as
described previously (Nussbaum et al., 1994).
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